Disease/Experimental Model

Includes refinements to animal models of aging, asthma, cancer, colitis, diabetes, epilepsy, polyarthritis, etc.

Rix, A., Drude, N., Mrugalla, A. et al. 2020. Performance of severity parameters to detect chemotherapy-induced pain and distress in mice. Laboratory Animals 54(5), 452-460.

According to European Union directive 2010/63/EU a severity classification of experimental procedures performed on laboratory animals is mandatory. This includes a prospective evaluation of all interventions performed within the experiment, as well as an assessment...

Singleton, S., Nefla, M., Dennison, N. et al. 2020. Assessing pain in models of rheumatoid arthritis. Animal Technology and Welfare 19(2), 149-152.

A hallmark symptom of rheumatoid arthritis in humans is painful swollen joints. Pain can manifest before any inflammation is noticeable as well as persist long after inflammation has resolved. In rodent models of arthritis, ankle...

Zhang, X., Kumstel, S., Tang, G. et al. 2020. A rational approach of early humane endpoint determination in a murine model for cholestasis. ALTEX 37(2), 197-207.

Reduction of animal suffering during in vivo experiments is usually ensured by continuously monitoring the health status using a score sheet and by applying humane endpoints. However, most studies do not evaluate the plausibility of...

Helgers, S., Talbot, S. R., Riedesel, A. K. et al. 2020. Body weight algorithm predicts humane endpoint in an intracranial rat glioma model. Scientific Reports 10, 9020.

Humane endpoint determination is fundamental in animal experimentation. Despite commonly accepted endpoint criteria for intracranial tumour models (20% body weight loss and deteriorated clinical score) some animals still die before being euthanized in current research...